Novo Nordisk India rolls-out a once-weekly basal insulin Awiqli

Novo Nordisk: Schritt für Schritt

Novo Nordisk: Vægttabsmedicin rykker ind i forbrugersegmentet og kan nå 100 mia. dollars i 2030

Novo Nordisks vægttabsmedicin (Wegovy, Ozempic) bevæger sig ind i et forbrugersegment, hvor kunder opfører sig som dagligvareforbrugere snar

Novo Nordisk pens long-acting GLP-1 implant tech deal with Vivani Medical

Novo Nordisk: Wachstum im Diabetes- und Adipositasmarkt – Innovation, Kapazitäten und Pipeline-Fokus

Novo Nordisk launches first GLP-1 weight loss pill Wegovy in US at lower price than injections

Novo Nordisk has launched the first pill version of its blockbuster GLP-1 weight loss drug Wegovy in the US at a significantly lower price t

Wegovy weight-loss pill goes on sale on UK high street and online pharmacies

Wegovy weight-loss pill goes on sale on UK high street and online pharmacies